Why Did SoFi Stock Drop?
Fintech platform SoFi (NASDAQ:SOFI) has stumbled in recent days, selling…
Sell
37
CGON Quote, Financials, Valuation and Earnings
Last price:
$43.29
Seasonality move
:
-29.45%
Day range:
$43.02 - $46.01
52-week range:
$14.80 - $46.01
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1,520.18x
P/B ratio:
4.80x
Volume:
745.5K
Avg. volume:
914.6K
1-year change:
29.02%
Market cap:
$3.3B
Revenue:
$1.1M
EPS (TTM):
-$1.98
Earnings Data
Next earnings date for CGON
Mar 26
2026
Most recent earnings per share
-$0.57
Missed by $0.02
(Nov 14/2025)
Consensus Estimate
-$0.55
(Nov 14/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
CGON Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/26/2026 | Q4 | $566.7K | -- | -- | -$0.59 | -- |
| 11/14/2025 | Q3 | $72.6K | $1.7M | -$0.57 | -$0.55 | -$0.02 |
| 08/08/2025 | Q2 | $108.7K | -- | -$0.54 | -$0.45 | -$0.09 |
| 05/13/2025 | Q1 | $124K | $52K | -$0.45 | -$0.37 | -$0.08 |
| 03/28/2025 | Q4 | $124.5K | $456K | -$0.42 | -$0.46 | $0.04 |
| 11/12/2024 | Q3 | $205.4K | $43K | -$0.30 | -$0.34 | $0.04 |
| 08/08/2024 | Q2 | $176.3K | $111K | -$0.28 | -$0.32 | $0.03 |
| 03/31/2024 | Q1 | -- | $529K | -$0.36 | -$0.15 | -$0.21 |
| 12/31/2023 | Q4 | -- | $1K | -$0.33 | -$1.00 | $0.67 |
| 09/30/2023 | Q3 | -- | $9K | -$0.28 | -- | -- |
| 06/30/2023 | Q2 | -- | -- | -$0.23 | -- | -- |
| 03/31/2023 | Q1 | -- | $194K | -$2.86 | -- | -- |
| 12/31/2022 | Q4 | -- | -- | -$0.18 | -- | -- |
CG Oncology, Inc. Earnings Questions
-
How Much did CG Oncology, Inc. Generate in Revenue Last Quarter?
CG Oncology, Inc. reported $1.7M worth of top line sales in its most recent quarter.
-
Did CG Oncology, Inc. Beat Earnings Last Quarter?
CG Oncology, Inc. announced earnings per share of -$0.57 which represents a miss of analyst forecast a -$0.55 per share.
-
Is CG Oncology, Inc. Profitable?
CG Oncology, Inc. reported -$327K that represents -$0.00 per share over the last quarter.
-
What is the Analyst Consensus for CG Oncology, Inc. EPS Next Year?
CG Oncology, Inc.'s earnings are forecast to decrease from -$1.16 per share to -$1.35 per share next year representing a decrease of -82.39%.
-
When is CG Oncology, Inc.'s Earnings Date?
CG Oncology, Inc.'s next earnings date is March 26, 2026.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Robinhood Win AI Investing?
Recently, online brokerage Robinhood (NASDAQ:HOOD) has been focused on introducing…
Is Amazon an AI Stock?
With the market starting to look skittish on pure-play AI…
Stock Ideas
Buy
52
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 62x
Buy
56
Is AAPL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 37x
Buy
81
Is GOOG Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 40x
Alerts
Sell
50
TGL alert for Dec 8
Treasure Global, Inc. [TGL] is up 65.06% over the past day.
Buy
56
SMX alert for Dec 8
SMX (Security Matters) Plc [SMX] is down 48.08% over the past day.
Buy
62
PRAX alert for Dec 8
Praxis Precision Medicines, Inc. [PRAX] is up 5.53% over the past day.
